BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27515395)

  • 1. Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study.
    Braquet P; Alla F; Cornu C; Goehringer F; Piroth L; Chirouze C; Revest M; Lechiche C; Duval X; Le Moing V;
    Clin Microbiol Infect; 2016 Nov; 22(11):948.e1-948.e7. PubMed ID: 27515395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
    Forsblom E; Ruotsalainen E; Mölkänen T; Ollgren J; Lyytikäinen O; Järvinen A
    J Hosp Infect; 2011 Jun; 78(2):102-7. PubMed ID: 21511366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy.
    Gómez J; García-Vázquez E; Baños R; Canteras M; Ruiz J; Baños V; Herrero JA; Valdés M
    Eur J Clin Microbiol Infect Dis; 2007 Apr; 26(4):239-45. PubMed ID: 17318479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?
    López-Cortés LE; Velasco C; Retamar P; del Toro MD; Gálvez-Acebal J; de Cueto M; García-Luque I; Caballero FJ; Pascual A; Rodríguez-Baño J
    J Antimicrob Chemother; 2015 Sep; 70(9):2652-60. PubMed ID: 26023210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
    Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
    Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
    Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
    Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals.
    Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Martín-Gandul C; López-Medrano F; de Gopegui ER; Ramón Blanco J; García-Pardo G; Calbo E; Horcajada JP; Granados A; Jover-Sáenz A; Dueñas C; Pujol M;
    Clin Microbiol Infect; 2014 Apr; 20(4):361-7. PubMed ID: 23991832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.
    Yaw LK; Robinson JO; Ho KM
    Lancet Infect Dis; 2014 Oct; 14(10):967-75. PubMed ID: 25185461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcus aureus bacteraemia in children and neonates: a 10 year retrospective review.
    Denniston S; Riordan FA
    J Infect; 2006 Dec; 53(6):387-93. PubMed ID: 16476482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
    Davis JS; Turnidge J; Tong S
    Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre.
    Kaech C; Elzi L; Sendi P; Frei R; Laifer G; Bassetti S; Fluckiger U
    Clin Microbiol Infect; 2006 Apr; 12(4):345-52. PubMed ID: 16524411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
    Ruotsalainen E; Järvinen A; Koivula I; Kauma H; Rintala E; Lumio J; Kotilainen P; Vaara M; Nikoskelainen J; Valtonen V;
    J Intern Med; 2006 Feb; 259(2):179-90. PubMed ID: 16420547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia.
    Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Warren SJ; Gao W; Johnson PD; Howden BP
    Clin Microbiol Infect; 2013 Dec; 19(12):1163-8. PubMed ID: 23441652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
    Nissen JL; Skov R; Knudsen JD; Ostergaard C; Schønheyder HC; Frimodt-Møller N; Benfield T
    J Antimicrob Chemother; 2013 Aug; 68(8):1894-900. PubMed ID: 23599360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.
    Jensen AG; Wachmann CH; Espersen F; Scheibel J; Skinhøj P; Frimodt-Møller N
    Arch Intern Med; 2002 Jan; 162(1):25-32. PubMed ID: 11784216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feedback to clinicians on preventable factors can reduce hospital onset Staphylococcus aureus bacteraemia rates.
    Kok J; O'Sullivan MV; Gilbert GL
    J Hosp Infect; 2011 Oct; 79(2):108-14. PubMed ID: 21741724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology, course and prognosis of Staphylococcus aureus bacteremia--Preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort].
    Seifert H; Wisplinghoff H; Kaasch A; Achilles K; Langhorst A; Peyerl-Hoffmann G; Woehrmann A; Fätkenheuer G; Salzberger B; Kern WV
    Dtsch Med Wochenschr; 2008 Feb; 133(8):340-5. PubMed ID: 18270913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.
    Lesens O; Methlin C; Hansmann Y; Remy V; Martinot M; Bergin C; Meyer P; Christmann D
    Infect Control Hosp Epidemiol; 2003 Dec; 24(12):890-6. PubMed ID: 14700403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.